Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Peter, Schnülle"'
Autor:
J. Floege, Bernd Krüger, Bernhard Banas, Peter Schnülle, Christian Hugo, Bernhard K. Krämer, K. Schwenke, J. Galle
Publikováno v:
Nieren- und Hochdruckkrankheiten. 49:452-460
Autor:
Michael Keese, Matthias K. Jung, Babak Yazdani, Bernhard K. Krämer, Kay Schwenke, Julian Marinez, Bernd Krüger, Gangyi Chen, Peter Schnülle, Anna-Isabelle Kälsch, Jan Leipe, Philipp Nuhn, Urs Benck
Publikováno v:
Transplantation proceedings. 53(7)
Postmortal organ donor rates remain low in Germany, whereas donor age has been increasing considerably in the last decades. As a consequence of low donation rates older and more marginal donor kidneys are accepted for transplantation. However, procur
Autor:
Kai Nowak, Urs Benck, J. Haas, J. Brust, Bernhard K. Krämer, Peter Schnülle, Bernd Krüger, T. Singer, Uwe Gottmann
Publikováno v:
Transplantation Proceedings. 47:2791-2794
Renal transplantation in HIV-positive patients with end-stage renal disease has in recent years become a successful treatment option. We report two patients who underwent renal transplantation using a combination of basiliximab, calcineurin inhibitor
Autor:
Lothar A.J. Heinemann, K. M. Koch, Helmut Graf, Paul Michielsen, Peter Schnülle, Michael J. Mihatsch
BACKGROUND: A recent large-scale case-control study on analgesic nephropathy (SAN) [1] found no increased risk of end-stage renal disease (ESRD) in users of combined or single formulations of phenacetin-free analgesics. In a subgroup of 22 high users
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0deec3f41183456c878ed484939658c
http://doc.rero.ch/record/291321/files/gfn643.pdf
http://doc.rero.ch/record/291321/files/gfn643.pdf
Publikováno v:
Dialyse aktuell. 18:423-429
In gut selektionierten Einzelfallen konnen postmortale Spendernieren trotz bei Organentnahme bestehendem ANV/AKI mit guten Ergebnissen hinsichtlich der Transplantatfunktion und des Transplantatuberlebens transplantiert werden. Ein ANV/AKI ist unmitte
Publikováno v:
Der Nephrologe. 7:163-174
Die Dreifach („Triple“)-Therapie, bestehend aus Kalzineurininhibitor, Mycophenolsaure und Steroid stellt nach (Nieren-)Transplantation nach wie vor die Standardtherapie dar, wobei eine steroidfreie Immunsuppression und eine kalzineurininhibitorfr
Autor:
Matthias Schwarzbach, Ulrich Ronellenfitsch, Peter Schnülle, Roderich Bönninghoff, Christof Denz, Rainer Birck, Stefan Post, Johannes Weiss, Katrin Harrer
Publikováno v:
Langenbeck's Archives of Surgery. 395:11-17
Standardization of care is essential for improving outcome of kidney transplantation (KT). Clinical pathways (CPs) are known to standardize and improve perioperative care for a number of interventions. In transplantation medicine, however, pertinent
Publikováno v:
Transplant international : official journal of the European Society for Organ Transplantation. 29(9)
Kidney transplantation is a major medical improvement for patients with end-stage renal disease, but organ shortage limits its widespread use. As a consequence, the proportion of grafts procured from extended criteria donors (ECD) has increased consi
Autor:
Wilhelm Kriz, Irmgard Neumann, Peter Schnülle, Rüdiger Waldherr, Benito A. Yard, Fokko J. van der Woude, Rainer Birck, Mark Newman, Kyuichi Nemoto
Publikováno v:
Kidney International. 64:140-148
SCG/Kinjoh mice: A model of ANCA-associated crescentic glomerulonephritis with immune deposits. Background Spontaneous crescentic glomerulonephritis-forming/Kinjoh (SCG/Kj) mice spontaneously develop crescentic glomerulonephritis (CGN), systemic vasc
Autor:
Caner Süsal, Bernd Döhler, Gerhard Opelz, Peter Schnülle, Manfred Wiesel, Constanze Schönemann, Steffen Pelzl
Publikováno v:
Transplantation. 73:3-6
BACKGROUND In the present study, we investigated whether the soluble form of CD30 (sCD30), a marker for T helper 2-type cytokine-producing T cells, is increased in sera of potential kidney graft recipients. We also investigated whether the pretranspl